Vendor Risk Assessment in Pharmacovigilance

Introduction

Not all vendors create the same level of pharmacovigilance risk.

A vendor providing translation services presents a different risk profile than a vendor responsible for expedited safety reporting.

Despite this reality, some organisations apply identical oversight approaches to all vendors.

This frequently results in:

• Excessive oversight of low-risk vendors
• Insufficient oversight of high-risk vendors
• Inefficient use of resources
• Inspection findings

Risk assessment helps solve this problem.

By understanding vendor risk, organisations can allocate oversight effort proportionally and maintain stronger control of outsourced activities.

Why Vendor Risk Assessment Matters

Modern pharmacovigilance systems rely heavily on outsourcing.

Examples include:

• Case processing
• Literature surveillance
• Aggregate reporting
• Safety database hosting
• Medical information services
• Signal management support

Each outsourced activity introduces uncertainty.

The objective of vendor risk assessment is not to eliminate risk.

The objective is to:

• Understand risk
• Prioritise risk
• Control risk

This enables organisations to focus attention where it matters most.

The Regulatory Perspective

Regulators generally expect a risk-based approach to pharmacovigilance governance.

This principle applies equally to vendor oversight.

Inspectors frequently ask:

• How were vendors classified?
• Why was audit frequency selected?
• How were oversight activities determined?
• Which vendors are considered critical?

Without a structured risk model, these questions become difficult to answer consistently.

What Is Vendor Risk?

Vendor risk refers to the possibility that a vendor's activities could negatively affect:

• Patient safety
• Regulatory compliance
• Data integrity
• Operational continuity
• Product quality
• Inspection outcomes

The severity of risk depends upon both:

• The activity performed
• The consequences of failure

Understanding both dimensions is essential.

Risk-Based Oversight

One of the most important principles in vendor governance is:

Oversight effort should be proportional to risk.

A low-risk vendor may require:

• Basic monitoring
• Periodic review

A critical vendor may require:

• Enhanced KPIs
• Frequent governance meetings
• Audits
• QPPV visibility
• Senior management oversight

Risk assessment helps determine these requirements.

Common Vendor Risk Factors

Several factors commonly influence risk classification.

Regulatory Impact

Would vendor failure create regulatory non-compliance?

Examples:

• Expedited reporting vendors
• Aggregate reporting vendors

Typically associated with higher risk.

Patient Safety Impact

Could failure directly affect patient safety?

Examples:

• Signal management support
• Safety case handling

Often considered critical activities.

Data Integrity Impact

Does the vendor manage or process safety data?

Examples:

• Safety databases
• Data migration providers

Data integrity failures can have significant consequences.

Business Continuity Impact

Could operations continue if the vendor became unavailable?

Examples:

• Sole-source vendors
• Critical technology providers

Dependency increases risk.

Geographic Scope

How many regions depend on the vendor?

A global provider may create greater risk than a local provider.

Operational Complexity

Complex activities generally require greater oversight.

Examples:

• Signal detection support
• Aggregate reporting

versus

• Translation services

A Practical Risk Classification Model

Many organisations classify vendors into categories.

Low Risk

Characteristics:

• Limited compliance impact
• Limited patient safety impact
• Easy replacement

Example:

• Translation vendor

Medium Risk

Characteristics:

• Moderate operational importance
• Some compliance implications

Example:

• Medical information support

High Risk

Characteristics:

• Direct compliance impact
• Significant oversight requirements

Example:

• Literature surveillance vendor

Critical Risk

Characteristics:

• Direct effect on compliance
• Direct effect on patient safety
• Significant dependency

Examples:

• Safety database provider
• Case processing vendor

The precise terminology may differ between organisations.

The principle remains the same.

Critical Vendors

Critical vendors deserve particular attention.

A useful question is:

If this vendor failed tomorrow, what would happen?

If the answer includes:

• Missed reporting deadlines
• Safety reporting failures
• Significant compliance risk

the vendor may be critical.

Critical vendors often require:

• Enhanced governance
• Enhanced metrics
• Enhanced audit activity
• Greater management visibility

Building a Risk Scoring Model

Many organisations use scoring frameworks.

Example:

Total scores can support classification decisions.

The exact scoring system is less important than consistency.

Risk Assessment During Vendor Selection

Risk assessment should begin before contracting.

Questions include:

• Does the vendor have relevant experience?
• Does the vendor have PV expertise?
• Does the vendor have adequate resources?
• Does the vendor have quality systems?

Early assessment reduces downstream risk.

For additional information see:

[[vendor-qualification-and-selection]]

Risk Assessment During Operations

Risk assessment is not a one-time activity.

Vendor risk changes over time.

Examples include:

• Scope expansion
• Organisational changes
• Performance deterioration
• Technology changes

Periodic reassessment helps ensure oversight remains appropriate.

Risk Assessment and Audit Frequency

Risk assessment often drives audit planning.

Example:

The objective is efficient allocation of audit resources.

For additional information see:

[[vendor-audits]]

Risk Assessment and KPIs

Higher-risk vendors often require more detailed monitoring.

Examples include:

• Reporting compliance
• Quality review outcomes
• CAPA performance
• Escalation compliance

Metrics should reflect risk exposure.

For additional information see:

[[vendor-kpis-and-metrics]]

Risk Assessment and QPPV Oversight

The QPPV should have visibility regarding critical vendor risks.

Examples include:

• Significant compliance issues
• Major deviations
• High-risk vendors
• Escalated CAPAs

Risk assessment helps determine where QPPV attention should be focused.

Common Risk Assessment Mistakes

Several mistakes occur repeatedly.

One-Time Assessments

Risk assessments are performed once and never reviewed.

Equal Treatment

All vendors receive identical oversight.

Excessive Complexity

Scoring models become difficult to maintain.

Poor Documentation

Risk rationales are not recorded.

Ignoring Organisational Dependency

The vendor appears low risk but supports critical processes.

These weaknesses often become apparent during inspections.

Inspection Perspective

Inspectors frequently examine:

• Risk classification approaches
• Oversight models
• Audit frequency
• Governance intensity

The key question is often:

Does the level of oversight match the level of risk?

Strong risk assessment frameworks help answer this convincingly.

Characteristics of Mature Vendor Risk Management

High-performing organisations generally demonstrate:

Structured Classification

Risk categories are defined.

Documented Rationale

Decisions are explainable.

Periodic Reassessment

Risk is reviewed regularly.

Risk-Based Oversight

Controls match risk.

Governance Integration

Risk information influences decision making.

These characteristics support sustainable oversight.

Key Takeaways

• Vendor risk assessment is the foundation of risk-based oversight.
• Not all vendors require the same level of governance.
• Regulatory impact, patient safety impact and dependency are key risk factors.
• Critical vendors require enhanced oversight.
• Risk assessment should influence audits, metrics and governance activities.
• Risk should be reassessed periodically.
• Inspectors often evaluate whether oversight is proportional to risk.

References

1. EMA Good Pharmacovigilance Practices (GVP) Module I – Pharmacovigilance Systems and Their Quality Systems.
2. EMA Good Pharmacovigilance Practices (GVP) Module III – Pharmacovigilance Inspections.
3. EMA Good Pharmacovigilance Practices (GVP) Module II – Pharmacovigilance System Master File.
4. Regulation (EC) No 726/2004.
5. Directive 2001/83/EC.
6. Commission Implementing Regulation (EU) No 520/2012.
7. ICH Q9 Quality Risk Management.
8. ICH E2E Pharmacovigilance Planning.